Navigation Links
New Treatment Discovered For Pediatric Cholera

Single dose of antibiotics may be used to treat childhood cholera.

Researchers in Bangladesh have found that severe cholera in children can be treated effectively with a single dose // of the antibiotic ciprofloxacin , according to a study published online by The Lancet.

Cholera is a major global health problem particularly in children in areas in less-developed countries. In the resource-limited countries where cholera occurs, any reduction in hospital stay is important as it reduces the demands on the healthcare system. Currently, WHO recommends a 3-day, 12-dose course of antibiotic treatment with either tetracycline or erythromycin for treatment of cholera in children.

Researchers from Center for Health and Population Research, Bangladesh had compared the effectiveness of a 3-day, 12-dose course of erythromycin with a single-dose of ciprofloxacin. 162 children were randomly assigned to treatment with either ciprofloxacin or erythromycin. Treatment with ciprofloxacin was successful within 48 hours in 60% of cases, compared with 55% in children who were treated with erythromycin. Ciprofloxacin was more effective than erythromycin at reducing vomiting and stool number and volume. However, single-dose ciprofloxacin was inferior to erythromycin in eradicating the cholera bacteria—Vibrio cholerae—resulting in those treated with ciprofloxacin excreting the bacteria for longer than those treated with erythromycin.

Dr Saha, the main author of the study, concludes: “For infections caused by susceptible strains of V cholerae, single-dose ciprofloxacin achieves clinical outcomes similar to or better than, those achieved with 12-dose erythromycin treatment in childhood cholera, but is less effective in eradicating Vcholeraefrom stool”

Source: The Lancet, Newswis
'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important ... problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , She developed ... darkness or restricted lighting. As such, it eliminates the need to turn on a ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , which ... evacuation of the facility as part of a disaster drill on October 3rd. , ... and Shelton City Emergency Manager, as well as the Connecticut Long Term Care ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor ... on sciatica in a new episode of "Success Files," which is an award-winning ... innovation and investigates each subject in-depth with passion and integrity. , Sciatica occurs ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/18/2017)... ALLENTOWN , Pa. and KALAMAZOO, Mich. ... Allentown, Penn. , and OptiMed Specialty Pharmacy ... a business partnership to offer a strategic hub service ... PMD Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, ... A spirometer is a medical device used ...
Breaking Medicine Technology: